Table 3.
Primary Treatment of Patients with Trichosporon Fungemia According to Outcome
| Treatment, No. (%) | Total | Positive | Negative | P Value |
|---|---|---|---|---|
| Fluconazole | 22 | 12 (54.5) | 10 (45.5) | .436 |
| Voriconazole | 18 | 12 (66.7) | 6 (33.3) | |
| Fluconazole | 22 | 12 (54.5) | 10 (45.5) | .029 |
| AmB | 72 | 21 (29.2) | 51 (70.8) | |
| Fluconazole | 22 | 12 (54.5) | 10 (45.5) | .661 |
| AmB + azoles | 28 | 17 (60.7) | 11 (39.3) | |
| Voriconazole | 18 | 12 (66.7) | 6 (33.3) | .003 |
| AmB | 72 | 21 (29.2) | 51 (70.8) | |
| Voriconazole | 18 | 12 (66.7) | 6 (33.3) | .683 |
| AmB + azoles | 28 | 17 (60.7) | 11 (39.3) | |
| AmB | 72 | 21 (29.2) | 51 (70.8) | .003 |
| AmB + azoles | 28 | 17 (60.7) | 11 (39.3) |
Abbreviations: AmB, amphotericin B/liposomal amphotericin B.